Hale BG - Search Results

1

Autoantibodies targeting type I interferons: Prevalence, mechanisms of induction, and association with viral disease susceptibility.

Hale BG. Hale BG. Eur J Immunol. 2023 Jun;53(6):e2250164. doi: 10.1002/eji.202250164. Eur J Immunol. 2023. PMID: 37027328 Free article. Review.

2

Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.

Busnadiego I, Abela IA, Frey PM, Hofmaenner DA, Scheier TC, Schuepbach RA, Buehler PK, Brugger SD, Hale BG. Busnadiego I, et al. Among authors: hale bg. PLoS Biol. 2022 Jul 5;20(7):e3001709. doi: 10.1371/journal.pbio.3001709. eCollection 2022 Jul. PLoS Biol. 2022. PMID: 35788562 Free PMC article.

3

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.

Busnadiego I, Fernbach S, Pohl MO, Karakus U, Huber M, Trkola A, Stertz S, Hale BG. Busnadiego I, et al. Among authors: hale bg. mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20. mBio. 2020. PMID: 32913009 Free PMC article.

4

Interferon system deficiencies exacerbating severe pandemic virus infections.

Stertz S, Hale BG. Stertz S, et al. Among authors: hale bg. Trends Microbiol. 2021 Nov;29(11):973-982. doi: 10.1016/j.tim.2021.03.001. Epub 2021 Mar 20. Trends Microbiol. 2021. PMID: 33757684 Free PMC article. Review.

5

Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon.

Mair NK, Hale BG. Mair NK, et al. Among authors: hale bg. Sci Rep. 2022 Sep 13;12(1):15360. doi: 10.1038/s41598-022-19648-w. Sci Rep. 2022. PMID: 36100643 Free PMC article.

6

Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome.

Achleitner M, Mair NK, Dänhardt J, Kardashi R, Puhan MA, Abela IA, Toepfner N, de With K, Kanczkowski W, Jarzebska N, Rodionov RN, Wolf C, Lee-Kirsch MA, Steenblock C, Hale BG, Bornstein SR. Achleitner M, et al. Among authors: hale bg. Open Forum Infect Dis. 2023 Dec 19;11(1):ofad641. doi: 10.1093/ofid/ofad641. eCollection 2024 Jan. Open Forum Infect Dis. 2023. PMID: 38179103 Free PMC article.

7

SARS-CoV-2 variants reveal features critical for replication in primary human cells.

Pohl MO, Busnadiego I, Kufner V, Glas I, Karakus U, Schmutz S, Zaheri M, Abela I, Trkola A, Huber M, Stertz S, Hale BG. Pohl MO, et al. Among authors: hale bg. PLoS Biol. 2021 Mar 24;19(3):e3001006. doi: 10.1371/journal.pbio.3001006. eCollection 2021 Mar. PLoS Biol. 2021. PMID: 33760807 Free PMC article.

8

Proteomic Approaches to Dissect Host SUMOylation during Innate Antiviral Immune Responses.

Lork M, Lieber G, Hale BG. Lork M, et al. Among authors: hale bg. Viruses. 2021 Mar 23;13(3):528. doi: 10.3390/v13030528. Viruses. 2021. PMID: 33806893 Free PMC article. Review.

9

BRD9 is a druggable component of interferon-stimulated gene expression and antiviral activity.

Börold J, Eletto D, Busnadiego I, Mair NK, Moritz E, Schiefer S, Schmidt N, Petric PP, Wong WW, Schwemmle M, Hale BG. Börold J, et al. Among authors: hale bg. EMBO Rep. 2021 Oct 5;22(10):e52823. doi: 10.15252/embr.202152823. Epub 2021 Aug 16. EMBO Rep. 2021. PMID: 34397140 Free PMC article.

10

Antiviral immunity triggered by infection-induced host transposable elements.

Hale BG. Hale BG. Curr Opin Virol. 2022 Feb;52:211-216. doi: 10.1016/j.coviro.2021.12.006. Epub 2021 Dec 24. Curr Opin Virol. 2022. PMID: 34959082 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page